T2D and obesity have been associated with a genetic polymorphism of IL-6 (−174 G/C) [109], supporting that level of expression of this molecule may influence metabolic homeostasis. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.